Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002102
Filing Date
2025-01-06
Accepted
2025-01-06 16:15:12
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6023
  Complete submission text file 0000950170-25-002102.txt   7494
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 40 GUEST STREET BOSTON MA 02134
Business Address
Janku Filip (Reporting) CIK: 0001862930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40522 | Film No.: 25511273